Chronic Venous Disease

Chronic venous disease is an important pathologic condition seen routinely by vascular surgeons. Varicose veins in the great saphenous vein (GSV) distribution are the most common manifestations of chronic venous disease and are present in 20% to 25% of women and in 10% to 15% of men . Saphenous reflux was once treated routinely with saphenofemoral ligation and vein stripping but now can be managed with multiple less-invasive therapies. Endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and foam sclerotherapy are just as effective as the open procedure with less morbidity, faster recovery, and improved cosmetic results . Minimally invasive treatments aim to occlude the saphenous vein; however, high ligation of the great saphenous vein is not usually performed with these procedures. Radiofrequency ablation and EVLT offer comparable venous occlusion rates at three months after treatment of primary GSV varices with no statistical difference in efficacy. Radiofrequency ablation is associated with less periprocedural pain, analgesic requirement and bruising, making it the treatment of choice at some institutions . The RFA procedure is associated with the perioperative risk of paraesthesia (4% to 20%), phlebitis (7% to 9%), and bruising or skin pigmentation changes (6% to 19%). In addition, there is risk of endovenous heatinduced thrombosis and deep vein thrombosis (DVT) with a previously reported incidence of 0.3% after EVLT and 2.1% after RFA . This report presents a patient with an unknown patent foramen ovale (PFO) who underwent RFA of the great saphenous vein complicated by leftsided cerebral infarcts. scenario in which a patient suffered a major complication from a minimally invasive procedure. The prevalence of PFO in the patient population with concomitant GSV reflux is higher than anticipated. Currently, however, there does not appear to be strong evidence to support routine preoperative evaluation with TEE and bubble study due to the high cost and low overall complication rate of venous thromboembolism. OMICS Group International is one of the leading Open Access Publishing houses, which has around 700+ peer-reviewed journals, 50,000+ editorial board members, and highly qualified, expert reviewers to meet the objectives of the Peer-Review Process. OMICS Group International peer-review policies are highly appreciated, accepted and adaptable to the criteria that have been prescribed by the international agencies such as NIH, PubMed etc. OMICS Group International also organizes 3000+ International Scientific Conferences per year globally

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on November, 2024